110 related articles for article (PubMed ID: 35924963)
1. Development of a series of flurbiprofen and zaltoprofen platinum(IV) complexes with anti-metastasis competence targeting COX-2, PD-L1 and DNA.
Li Z; Li L; Zhao W; Sun B; Liu Z; Liu M; Han J; Wang Z; Li D; Wang Q
Dalton Trans; 2022 Aug; 51(33):12604-12619. PubMed ID: 35924963
[TBL] [Abstract][Full Text] [Related]
2. Development of Clioquinol Platinum(IV) Conjugates as Autophagy-Targeted Antimetastatic Agents.
Zhang M; Li L; Li S; Liu Z; Zhang N; Sun B; Wang Z; Jia D; Liu M; Wang Q
J Med Chem; 2023 Mar; 66(5):3393-3410. PubMed ID: 36891739
[TBL] [Abstract][Full Text] [Related]
3. Ketoprofen and Loxoprofen Platinum(IV) Complexes Displaying Antimetastatic Activities by Inducing DNA Damage, Inflammation Suppression, and Enhanced Immune Response.
Li Z; Wang Q; Li L; Chen Y; Cui J; Liu M; Zhang N; Liu Z; Han J; Wang Z
J Med Chem; 2021 Dec; 64(24):17920-17935. PubMed ID: 34852203
[TBL] [Abstract][Full Text] [Related]
4. A series of ligustrazine platinum(IV) complexes with potent anti-proliferative and anti-metastatic properties that exert chemotherapeutic and immunotherapeutic effects.
Chen Y; Li L; Liu Z; Liu M; Wang Q
Dalton Trans; 2023 Sep; 52(37):13097-13109. PubMed ID: 37664893
[TBL] [Abstract][Full Text] [Related]
5. Multi-specific niflumic acid platinum(IV) complexes displaying potent antitumor activities by improving immunity and suppressing angiogenesis besides causing DNA damage.
Li L; Zhang M; Jia D; Liu Z; Zhang N; Sun B; Wang Z; Liu M; Wang Q
Dalton Trans; 2022 Dec; 52(1):147-158. PubMed ID: 36472127
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of T-cell-mediated immune response via the PD-1/ PD-L1 axis in cholangiocarcinoma cells.
Suriyo T; Fuangthong M; Artpradit C; Ungtrakul T; Sricharunrat T; Taha F; Satayavivad J
Eur J Pharmacol; 2021 Apr; 897():173960. PubMed ID: 33617828
[TBL] [Abstract][Full Text] [Related]
7. Development of a series of 4-hydroxycoumarin platinum(IV) hybrids as antitumor agents: Synthesis, biological evaluation and action mechanism investigation.
Li G; Zhang J; Liu Z; Wang Q; Chen Y; Liu M; Li D; Han J; Wang B
J Inorg Biochem; 2019 May; 194():34-43. PubMed ID: 30826588
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and evaluation of bi-functional 7-hydroxycoumarin platinum(IV) complexes as antitumor agents.
Wang Q; Chen Y; Li G; Liu Z; Ma J; Liu M; Li D; Han J; Wang B
Bioorg Med Chem; 2019 May; 27(10):2112-2121. PubMed ID: 30981607
[TBL] [Abstract][Full Text] [Related]
9. Albumin-encapsulated Nanoparticles of Naproxen Platinum(IV) Complexes with Inflammation Inhibitory Competence Displaying Effective Antitumor Activities in vitro and in vivo.
Li L; Chen Y; Wang Q; Li Z; Liu Z; Hua X; Han J; Chang C; Wang Z; Li D
Int J Nanomedicine; 2021; 16():5513-5529. PubMed ID: 34429597
[TBL] [Abstract][Full Text] [Related]
10. A novel star-shaped trinuclear platinum(II) complex based on a 1,3,5-triazine core displaying potent antiproliferative activity against TNBC by the mitochondrial injury and DNA damage mechanism.
Wu Y; Zhao D; Shang J; Huang W; Chen Z
Dalton Trans; 2022 Jul; 51(29):10930-10942. PubMed ID: 35731536
[TBL] [Abstract][Full Text] [Related]
11. Multispecific Platinum(IV) Complex Deters Breast Cancer via Interposing Inflammation and Immunosuppression as an Inhibitor of COX-2 and PD-L1.
Jin S; Muhammad N; Sun Y; Tan Y; Yuan H; Song D; Guo Z; Wang X
Angew Chem Int Ed Engl; 2020 Dec; 59(51):23313-23321. PubMed ID: 32897000
[TBL] [Abstract][Full Text] [Related]
12. Naproxen platinum(iv) hybrids inhibiting cycloxygenases and matrix metalloproteinases and causing DNA damage: synthesis and biological evaluation as antitumor agents in vitro and in vivo.
Chen Y; Wang Q; Li Z; Liu Z; Zhao Y; Zhang J; Liu M; Wang Z; Li D; Han J
Dalton Trans; 2020 Apr; 49(16):5192-5204. PubMed ID: 32236281
[TBL] [Abstract][Full Text] [Related]
13. Series of Desloratadine Platinum(IV) Hybrids Displaying Potent Antimetastatic Competence by Inhibiting Epithelial-Mesenchymal Transition and Arousing Immune Response.
Zhang M; Chen Y; Liu Z; Liu M; Wang Q
J Med Chem; 2024 Feb; 67(3):2031-2048. PubMed ID: 38232132
[TBL] [Abstract][Full Text] [Related]
14. Ultrasound targeting of microbubble-bound anti PD-L1 mAb to enhance anti-tumor effect of cisplatin in cervical cancer xenografts treatment.
Ma Y; Han J; Jiang J; Zheng Z; Tan Y; Liu C; Zhao Y
Life Sci; 2020 Dec; 262():118565. PubMed ID: 33038371
[TBL] [Abstract][Full Text] [Related]
15. B7-H1 antibodies lose antitumor activity due to activation of p38 MAPK that leads to apoptosis of tumor-reactive CD8
Liu X; Wu X; Cao S; Harrington SM; Yin P; Mansfield AS; Dong H
Sci Rep; 2016 Nov; 6():36722. PubMed ID: 27824138
[TBL] [Abstract][Full Text] [Related]
16. R-flurbiprofen reverses multidrug resistance, proliferation and metastasis in gastric cancer cells by p75(NTR) induction.
Jin H; Wang Z; Liu L; Gao L; Sun L; Li X; Zhao H; Pan Y; Shi H; Liu N; Hong L; Liang J; Wu Q; Yang Z; Wu K; Fan D
Mol Pharm; 2010 Feb; 7(1):156-68. PubMed ID: 19916560
[TBL] [Abstract][Full Text] [Related]
17. N
Liu Z; Wang T; She Y; Wu K; Gu S; Li L; Dong C; Chen C; Zhou Y
Mol Cancer; 2021 Aug; 20(1):105. PubMed ID: 34416901
[TBL] [Abstract][Full Text] [Related]
18. Programmed Death Ligand 1 Indicates Pre-Existing Adaptive Immune Response by Tumor-Infiltrating CD8
Li YM; Yu JM; Liu ZY; Yang HJ; Tang J; Chen ZN
Int J Mol Sci; 2019 Oct; 20(20):. PubMed ID: 31627272
[TBL] [Abstract][Full Text] [Related]
19. PD-L1 blockade exhibits anti-tumor effect on brain metastasis by activating CD8
Masuda C; Morinaga M; Wakita D; Yorozu K; Kurasawa M; Sugimoto M; Kondoh O
Clin Exp Metastasis; 2022 Apr; 39(2):335-344. PubMed ID: 34797455
[TBL] [Abstract][Full Text] [Related]
20. Cisplatin Augments Antitumor T-Cell Responses Leading to a Potent Therapeutic Effect in Combination With PD-L1 Blockade.
Wakita D; Iwai T; Harada S; Suzuki M; Yamamoto K; Sugimoto M
Anticancer Res; 2019 Apr; 39(4):1749-1760. PubMed ID: 30952714
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
